Collective Impact: The participant group achieved a cumulative weight loss of 2,732 kg
Quick Answer: Persistent hunger on semaglutide may occur due to insufficient time at therapeutic dose, hormonal adaptation during weight loss, dietary composition, medication interactions, or individual variation in GLP-1 receptor response
Early trials suggest Retatrutide may be more potent, but its still under study
Be open to emerging solutions and new pharmacy benefit management strategies
The cohort skewed older, with 34.0% aged 4559 years and 37.8% aged 60 years or older
However, past pancreatitis is not a contraindication for these agents, and contrary to the previous warning, recent studies have not shown an increased pancreatic risk associated with GLP-1 RAs, leading to ongoing revisions in treatment guidelines